Significant research news last week included Regenxbio suffering a further setback in the development of RGX-121, with the US ...
Japan’s largest drugmaker Takeda announced that the US Food and Drug Administration (FDA) has approved the New Drug ...
US specialty pharma company Quoin Pharmaceuticals on Friday said it has entered into a securities purchase agreement to raise ...
ProFound Therapeutics, a Flagship Pioneering company based in Cambridge, Massachusetts, has received an investment commitment ...
US biotech major Moderna (Nasdaq: MRNA) plans to raise $2 billion through a private placement of convertible senior notes due ...
The US Food and Drug Administration (FDA) has approved Roivant subsidiary Priovant’s Lisraya (brepocitinib) 30mg for the treatment of adults with dermatomyositis (DM). Lisraya is a pill taken once ...
US biotech Moderna said the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized its updated ...
Swiss pharma major Roche has announced new two-year data from the Phase IIIb/IV SALWEEN study of Vabysmo (faricimab), ...
The US Food and Drug Administration (FDA) yesterday approved Rasonque (daraxonrasib), a RAS inhibitor for the most common ...
US pharma major Pfizer and German biotech firm BioNTech have secured US Food and Drug Administration (FDA) clearance for the ...
Northern Ireland-headquartered pharma company Galen has unveiled Galsana, a new global brand uniting its metabolic disease ...
French clinical-stage biotech Osivax and South Korean biopharmaceutical company GC Biopharma have entered a long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results